Details of the Drug

General Information of Drug (ID: DMXUU53)

Drug Name

PG11047

Indication

Disease Entry	ICD 11	Status	REF
Lymphoma	2A80-2A86	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT00705653) Study of CGC-11047 (PG-11047) in Subjects With Advanced Refractory Solid Tumors. U.S. National Institutes of Health.